Colorcon launches SoteriaRx on-dose authentication technology platform

Smart medications that can provide traceability from plant to patient.

Counterfeit drugs, which are estimated to be worth US$200 billion or 2% of total pharma revenue, financially affect the pharmaceutical industry and compromise patient safety.

Traceability and security measures focused at the packaging level are insufficient to deter fraud, especially in low- and middle-income countries where either substandard or falsified medicines can account for up to 70% of medications distributed internally.

The solution is smart medications with on-dose taggants that can be authenticated throughout the supply chain. Colorcon's SoteriaRx provides a powerful tool for tracking medicines from plant to patient and provides a level of supply chain authenticity and transparency not previously available.

By incorporating microtags, the pill itself effectively becomes a barcode which can be digitally read and recorded, providing instant authentication.

According to Colorcon CEO, Martti Hedman, this digitalization of medicines represents a "major step forward" in the fight against unauthorized and illegitimate pharmaceutical production and provides an opportunity to safeguard patients.